Clinical Trials Browser

Phase 2 × peginterferon alfa-2b × Gastrointestinal × Clear all

NCT02982720 2022-02-16

Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron

Phase 2 Terminated

4 enrolled 9 charts

Gastrointestinal

Cholangiocarcinoma

NCT00055809 2013-01-23

Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors

Phase 2 Completed

EndocrineGastrointestinal

Metastatic Gastrointestinal Carcinoid Tumor